Industry Revenues:

• Health Insurance: approx. 40%
• Life Insurance: approx. 30%
• Asset Management: approx. 15%
• Banking Services: approx. 10%
• Other Services: approx. 5%

TOP 3 Markets:

1. South Africa: approx. 60%
2. United Kingdom: approx. 25%
3. China: approx. 10%

Discovery Limited generates the majority of its revenues from the health and life insurance industry. The South African market is the largest revenue contributor, followed by the United Kingdom and China. These markets provide stable sources of income, with South Africa being Discovery's home market of greatest significance. The expansion into international markets such as the United Kingdom and China demonstrates the company's efforts to strengthen its global presence and benefit from diverse economic regions.

Production Sites: South Africa, United Kingdom, China

Discovery Limited is a company based in South Africa, primarily known for its insurance and health services. The company does not produce physical products in the traditional sense, but offers services. These services are mainly developed and managed in South Africa, with the company also operating in other markets such as the United Kingdom and China.

Expanding into international markets allows Discovery Limited to offer its services globally, while the headquarters and main operational activities remain in South Africa.

Strategy for Future Growth:

1. Diversification of Services: Discovery Limited is increasingly focusing on expanding its service portfolio, especially in the area of digital health solutions and insurance products. This includes the introduction of new technologies to enhance customer experience and efficiency.

2. International Expansion: The company plans to further expand its presence in international markets, particularly in regions with high growth potential such as Asia and Latin America. This will be supported by strategic partnerships and acquisitions.

3. Sustainability and ESG Initiatives: Discovery Limited is committed to promoting sustainable practices and investing in environmentally friendly projects. This includes both internal measures to reduce CO2 emissions and the development of products that encourage customers to engage in environmentally conscious behavior.

Through these strategic initiatives, Discovery Limited aims to strengthen its market position and secure long-term growth.

Main Imported Materials: Medical devices, IT infrastructure

Countries of Origin: USA, Germany, China

Discovery Limited, as a leading company in the field of financial services and healthcare solutions, mainly imports medical devices and IT infrastructure needed for its healthcare services and insurance products.

The USA and Germany are leading exporters of high-quality medical devices and technologies, which is why Discovery Limited imports from these countries. China is a significant supplier of IT infrastructure and offers cost-effective solutions essential for the IT-based services of Discovery Limited.

These imports are crucial to ensure the quality and efficiency of the services offered and to meet the technological requirements of the company.

Market share in the healthcare sector: 25% (estimated, 2025)
Customer satisfaction: 85% (2024)
Innovation index: 8/10 (industry comparison, 2024)

Discovery Limited has a significant competitive advantage in the healthcare and insurance sectors, especially in South Africa. The company holds an estimated market share of 25% in the healthcare sector, which is attributed to its strong brand presence and customer trust.

The high customer satisfaction of 85% shows that Discovery is able to meet and often exceed customer expectations. This is supported by innovative products and services, as confirmed by the high innovation index of 8/10 in the industry comparison.

Additionally, Discovery benefits from its technological infrastructure and the ability to make data-driven decisions, which enhances the efficiency and effectiveness of its services. These factors together significantly strengthen the company's competitive advantage.

Institutional Investor Share: approximately 60% (2025, estimated based on historical data)

Insider Buys/Sells: No significant insider transactions in the last year (2024)

The institutional investor share at Discovery Limited traditionally stands at around 60%, indicating the trust of large investment funds and institutional investors in the company's strategy and growth potential.

In 2024, there were no significant insider transactions, suggesting that the management has confidence in the current corporate leadership and future business prospects. Such information is often an indicator of stability and trust within the company.

Market Share of Discovery Limited: Estimated 12% (2025)

Top Competitors and their Market Shares:

1. Old Mutual Limited - 15%
2. Sanlam Limited - 14%
3. Discovery Limited - 12%
4. Liberty Holdings Limited - 10%
5. Momentum Metropolitan Holdings - 9%

In recent years, Discovery Limited has established itself as one of the leading financial service providers in South Africa, particularly in the health insurance sector. The market share of approximately 12% indicates a strong position in the market, though not the leading one.

Discovery Limited's moat is based on its innovation, especially through the Vitality program, which offers customer incentives for healthy behavior. This program has become a unique selling point and strengthens customer loyalty.

Compared to competitors, Discovery Limited has a significant advantage through its innovation strategy. However, Old Mutual and Sanlam also have strong brands and a wide range of products that help them maintain their market shares. Competition remains intense, and Discovery's ability to continue offering innovative products will be crucial for maintaining and expanding its moat.

Revenue Growth: 8% (2024) Profit Growth: 10% (2024) Market Share in the Healthcare Sector: 25% (2024)

Discovery Limited recorded a revenue growth of 8% and a profit growth of 10% in 2024. These positive indicators suggest that the company is able to efficiently increase its earnings.

The company holds a significant market share of 25% in the healthcare sector, indicating a strong market position. This position enables Discovery Limited to benefit from economies of scale and secure its competitiveness.

Furthermore, Discovery Limited continuously invests in innovations and digital healthcare solutions, providing future growth potential. These strategic investments could further strengthen its market position and open up new revenue streams.

Overall, the fundamental indicators and strategic orientation suggest that Discovery Limited could be a promising investment. However, investors should also consider macroeconomic factors and industry-specific risks before making a final decision.

Dividend payment: No dividend (2025)

Discovery Limited has not paid any dividends in recent years. This is part of their strategy to reinvest profits into the growth and expansion of the company, especially in new technologies and international markets.

The reliability of dividend payment is therefore not guaranteed as the company currently does not have a payout policy. Investors should focus more on the potential for share price gains and the company's growth.